Thu Oct 09 05:04:28 UTC 2025: Here’s a summary of the text followed by a rewritten version as a news article:
**Summary:**
G. Ranganathan, the owner of Sresan Pharmacy in Kancheepuram, Tamil Nadu, has been arrested in Chennai by a joint team from the Madhya Pradesh SIT and Chennai police. His arrest is in connection with the production of Coldrif cough syrup, which has been linked to the deaths of 21 children in Madhya Pradesh and Rajasthan. His manufacturing unit has been sealed and further investigation is ongoing. Laboratory analysis confirmed the presence of toxic substances in the cough syrup. The Madhya Pradesh government has banned the sale of Coldrif and all other medications manufactured by Sresan Pharmaceuticals.
**News Article:**
**Tamil Nadu Pharmacy Owner Arrested in Cough Syrup Death Investigation**
**CHENNAI, October 9, 2025** – G. Ranganathan, the proprietor of Kancheepuram-based Sresan Pharmacy, was arrested this morning in Chennai in connection with a deadly cough syrup scandal. A joint operation by the Madhya Pradesh Special Investigation Team (SIT) and Ashok Nagar police apprehended Ranganathan at his residence in Kodambakkam.
The arrest stems from allegations that Sresan Pharmacy produced the Coldrif cough syrup, which has been linked to the deaths of 21 children in Madhya Pradesh and Rajasthan. The company is accused of manufacturing a toxic product that led to the tragic loss of life.
“Following the arrest, a search was conducted at the company’s manufacturing unit in Sunguvarchatram, Kancheepuram, to examine production records and samples,” a police source confirmed. The facility, a 2,000 sq ft manufacturing plant along the Chennai–Bengaluru Highway, has since been sealed.
Madhya Pradesh police have charged Ranganathan under the provisions of the Bharatiya Nyaya Sanhita, and other applicable laws.
The investigation gained momentum after laboratory analysis in Tamil Nadu confirmed the presence of toxic substances in Coldrif cough syrup. This confirmation prompted the Madhya Pradesh government to issue a ban on the sale of Coldrif, as well as all other medications produced by Sresan Pharmaceuticals.
Residents near Ranganathan’s Kodambakkam office reported unusual activity last week, with staff seen removing equipment and computers late at night. The registered office is currently shuttered. The investigation is ongoing, with authorities working to determine the full extent of the company’s alleged negligence and culpability in the deaths of the children.
First Piper 